Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: Long-term follow up of three patients

Journal of the Neurological Sciences

Volumn 182, Issue 2, 2001, Pages 95-97

  Ohno, Takae ^a   Kobayashi, Shunsuke ^a   Hayashi, Masataka ^b   Sakurai, Masaki ^a   Kanazawa, Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Cerebrotendinous xanthomatosis; Chenodeoxycholic acid; Diphenylpyraline hydrochloride; Levodopa; Parkinsonism; Therapy

Indexed keywords

CARBIDOPA; CHENODEOXYCHOLIC ACID; CHOLESTANOL; DIPHENYLPYRALINE; LEVODOPA;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0035183764     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00441-X     Document Type: Article

References (11)

1. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis
2. Cerebrotendinous xanthomatosis: Clinical and MRI study (a case report)
3. Parkinsonism in cerebrotendinous xanthomatosis
4. PET analysis of a case of cerebrotendinous xanthomatosis presenting hemiparkinsonism
5. Some pharmacological and clinical experiences with Dimethylaminoethyl benzhydryl ether hydrochloride (Benadryl)
6. Effect of some antiparkinsonian drugs on cathecholamine neurons
7. Antiparkinsonian drugs and central dopamine neurons
8. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease
9. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporter 1 and 2
10. Cholestanol induces apoptosis of cerebellar neuronal cells
11. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid